Bioventus INC. (BVS) — 10-Q Filings

All 10-Q filings from Bioventus INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

Bioventus Swings to Profit Amidst Sales Dip, Cost Cuts Drive Turnaround — Nov 4, 2025 Risk: medium
Bioventus Inc. reported a significant turnaround in its financial performance for the nine months ended September 27, 2025, achieving a net income of $9.956 mil
Bioventus Q2 2025: Equity Shifts Amidst Steady Operations — Aug 6, 2025 Risk: medium
Bioventus Inc. (BVS) filed its 10-Q for the period ending June 28, 2025, indicating a continued operational period. The filing provides a snapshot of the compan
Bioventus Inc. Files Q1 2025 10-Q — May 6, 2025 Risk: medium
Bioventus Inc. filed its 10-Q for the period ending March 29, 2025. The filing details financial performance and operational updates for the first quarter of fi
Bioventus Inc. Files Q3 2024 10-Q Report — Nov 5, 2024 Risk: medium
Bioventus Inc. filed its 10-Q for the period ending September 28, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key fi
Bioventus Inc. Files 10-Q for Period Ending March 30, 2024 — May 7, 2024 Risk: low
Bioventus Inc. (BVS) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Bioventus Inc. filed a 10-Q report for the period ending March 30, 2024. The f

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX